Nitric oxide: An inhibitor of NF-κB/Rel system in glial cells

Brain Research Bulletin

Volumn 52, Issue 3, 2000, Pages 155-161

  Colasanti, Marco ^a,b   Persichini, Tiziana ^b  

^a ROMA TRE UNIVERSITY   (Italy)

^b Res Inst Infect Dis L S   (Italy)

Author keywords

Glial cells; HIV 1; I B; NF B; Nitric oxide; Rel proteins

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE;

DNA BINDING; GENE EXPRESSION REGULATION; GLIA CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS REPLICATION;

ANIMALS; HUMANS; NEUROGLIA; NF-KAPPA B; NITRIC OXIDE; PROTO-ONCOGENE PROTEINS; TRANSCRIPTION FACTOR RELB; TRANSCRIPTION FACTORS;

EID: 0034013014     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(00)00262-8     Document Type: Review

References (74)

1. Akama K.T., Albanese C., Pestell R.G., Van Eldik L.J. Amyloid beta-peptide stimulates nitric oxide production in astrocytes through an NFkappaB-dependent mechanism, USA. Proc. Natl. Acad. Sci. 95:1998;5795-5800.
2. Andrew P.J., Harant H., Lindley I.J. Nitric oxide regulates IL-8 expression in melanoma cells at the transcriptional level. Biochem. Biophys. Res. Commun. 214:1995;949-956.
3. Baltrons M.A., Agullo L., Garcia A. Dexamethasone up-regulates a constitutive nitric oxide synthase in cerebellar astrocytes but not in granule cells in culture. J. Neurochem. 64:1995;447-450.
4. Bonaiuto C., McDonald P.P., Rossi F., Cassatella M.A. Activation of nuclear factor-kappa B by beta-amyloid peptides and interferon-gamma in murine microglia. J. Neuroimmunol. 77:1997;51-56.
5. Chao C.C., Lokensgard J.R., Sheng W.S., Hu S., Peterson P.K. IL-1-induced iNOS expression in human astrocytes via NF-kappa B. Neuroreport. 8:1997;3163-3166.
6. Chen C.C., Wang J.K., Chen W.C., Lin S.B. Protein kinase C eta mediates lipopolysaccharide-induced nitric-oxide synthase expression in primary astrocytes. J. Biol. Chem. 273:1998;19424-19430.
7. Chen F., Kuhn D.C., Sun S.C., Gaydos L.J., Demers L.M. Dependence and reversal of nitric oxide production on NF-kappa B in silica and lipopolysaccharide-induced macrophages. Biochem. Biophys. Res. Commun. 214:1995;839-846.
8. Chen F., Lu Y., Castranova V., Rojanasakul Y., Miyahara K., Shizuta Y., Vallyathan V., Shi X., Demers L.M. Nitric oxide inhibits HIV tat-induced NF-kappaB activation. Am. J. Pathol. 155:1999;275-284.
9. Colasanti M., Persichini T., Menegazzi M., Mariotto S., Giordano E., Caldarera C.M., Sogos V., Lauro G.M., Suzuki H. Induction of nitric oxide synthase mRNA expression. Suppression by exogenous nitric oxide. J. Biol. Chem. 270:1995;26731-26733.
10. Colasanti M., Cavalieri E., Persichini T., Mollace V., Mariotto S., Suzuki H., Lauro G.M. Bacterial lipopolysaccharide plus interferon-gamma elicit a very fast inhibition of a Ca2+-dependent nitric-oxide synthase activity in human astrocytoma cells. J. Biol. Chem. 272:1997;7582-7585.
11. Colasanti M., Persichini T., Fabrizi C., Cavalieri E., Venturini G., Ascenzi P., Lauro G.M., Suzuki H. Expression of a NOS-III-like protein in human astroglial cell culture. Biochem. Biophys. Res. Commun. 252:1998;552-555.
12. Colasanti M., Persichini T., Cavalieri E., Fabrizi C., Mariotto S., Menegazzi M., Lauro G.M., Suzuki H. Rapid inactivation of NOS-I by lipopolysaccharide plus interferon-gamma-induced tyrosine phosphorylation. J. Biol. Chem. 274:1999;9915-9917.
13. De Caterina R., Libby P., Peng H.B., Thannickal V.J., Rajavashisth T.B., Gimbrone M.A. Jr, Shin W.S., Liao J.K. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest. 96:1995;60-68.
14. DelaTorre A., Schroeder R.A., Kuo P.C. Alteration of NF-kappa B p50 DNA binding kinetics by S-nitrosylation. Biochem. Biophys. Res. Commun. 238:1997;703-706.
15. DelaTorre A., Schroeder R.A., Bartlett S.T., Kuo P.C. Differential effects of nitric oxide-mediated S-nitrosylation on p50 and c-jun DNA binding. Surgery. 124:1998;137-141.
16. DelaTorre A., Schroeder R.A., Punzalan C., Kuo P.C. Endotoxin-mediated S-nitrosylation of p50 alters NF-kappa B-dependent gene transcription in ANA-1 murine macrophages. J. Immunol. 162:1999;4101-4108.
17. DeMeester S.L., Qiu Y., Buchman T.G., Hotchkiss R.S., Dunnigan K., Karl I.E., Cobb J.P. Nitric oxide inhibits stress-induced endothelial cell apoptosis. Crit. Care Med. 26:1998;1500-1509.
18. Díaz-Cazorla M., Pérez-Sala D., Lamas S. Dual effect of nitric oxide donors on cyclooxygenase-2 expression in human mesangial cells. J. Am. Soc. Nephrol. 10:1999;943-952.
19. Feinstein D.L., Galea E., Reis D.J. Suppression of glial nitric oxide synthase induction by heat shock Effects on proteolytic degradation of IkappaB-alpha . Nitric Oxide. 1:1997;167-176.
20. Fiebich B.L., Butcher R.D., Gebicke-Haerter P.J. Protein kinase C-mediated regulation of inducible nitric oxide synthase expression in cultured microglial cells. J. Neuroimmunol. 92:1998;170-178.
21. Ghosh S., May M.J., Kopp E.B. NF-kappa B and Rel proteins Evolutionarily conserved mediators of immune responses . Annu. Rev. Immunol. 16:1998;225-260.
22. Goldring C.E., Narayanan R., Lagadec P., Jeannin J.F. Transcriptional inhibition of the inducible nitric oxide synthase gene by competitive binding of NF-kappa B/Rel proteins. Biochem. Biophys. Res. Commun. 209:1995;73-79.
23. Gozal E., Simakajornboon N., Gozal D. NF-kappaB induction during in vivo hypoxia in dorsocaudal brain stem of rat Effect of MK-801 and L-NAME . J. Appl. Physiol. 85:1998;372-376.
24. Griffin G.E., Leung K., Folks T.M., Kunkel S., Nabel G.J. Activation of HIV gene expression during monocyte differentiation by induction of NF-kappa B. Nature. 339:1989;70-73.
25. Grilli M., Memo M. Nuclear factor-kappaB/Rel proteins A point of convergence of signalling pathways relevant in neuronal function and dysfunction . Biochem. Pharmacol. 57:1999;1-7.
26. Griscavage J.M., Rogers N.E., Sherman M.P., Ignarro L.J. Inducible nitric oxide synthase from a rat alveolar macrophage cell line is inhibited by nitric oxide. J. Immunol. 151:1993;6329-6337.
27. Hartlage-Rubsamen M., Lemke R., Schliebs R. Interleukin-1beta, inducible nitric oxide synthase, and nuclear factor-kappaB are induced in morphologically distinct microglia after rat hippocampal lipopolysaccharide/interferon-gamma injection. J. Neurosci. Res. 57:1999;388-398.
28. Hori K., Burd P.R., Furuke K., Kutza J., Weih K.A., Clouse K.A. Human immunodeficiency virus-1-infected macrophages induce inducible nitric oxide synthase and nitric oxide (NO) production in astrocytes Astrocytic NO as a possible mediator of neural damage in acquired immunodeficiency syndrome . Blood. 93:1999;1843-1850.
29. Janssen-Heininger Y.M., Macara I., Mossman B.T. Cooperativity between oxidants and tumor necrosis factor in the activation of nuclear factor (NF)-kappaB Requirement of Ras/mitogen-activated protein kinases in the activation of NF- kappaB by oxidants . Am. J. Respir. Cell. Mol. Biol. 20:1999;942-952.
30. Katsuyama K., Shichiri M., Marumo F., Hirata Y. NO inhibits cytokine-induced iNOS expression and NF-kappaB activation by interfering with phosphorylation and degradation of IkappaB-alpha. Arterioscler. Thromb. Vasc. Biol. 18:1998;1796-1802.
31. Khan B.V., Harrison D.G., Olbrych M.T., Alexander R.W., Medford R.M. Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells, USA. Proc. Natl. Acad. Sci. 93:1996;9114-9119.
32. Koradi R., Billeter M., Wüthrich K. MOLMOL A program for display and analysis of macromolecular structures . J. Mol. Graph. 14:1996;51-55.
33. Kupatt C., Weber C., Wolf D.A., Becker B.F., Smith T.W., Kelly R.A. Nitric oxide attenuates reoxygenation-induced ICAM-1 expression in coronary microvascular endothelium Role of NFkappaB . J. Mol. Cell Cardiol. 29:1997;2599-2609.
34. Lander H.M., Sehajpal P., Levine D.M., Novogrodsky A. Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J. Immunol. 150:1993;1509-1516.
35. Lander H.M., Sehajpal P.K., Novogrodsky A. Nitric oxide signaling A possible role for G proteins . J. Immunol. 151:1993;7182-7187.
36. Lander H.M., Ogiste J.S., Pearce S.F., Levi R., Novogrodsky A. Nitric oxide-stimulated guanine nucleotide exchange on p21ras. J. Biol. Chem. 270:1995;7017-7020.
37. Lin H.L., Murphy S. Regulation of astrocyte nitric oxide synthase type II expression by ATP and glutamate involves loss of transcription factor binding to DNA. J. Neurochem. 69:1997;612-616.
38. Mariotto S., Cuzzolin L., Adami A., Del Soldato P., Suzuki H., Benoni G. Inhibition by sodium nitroprusside of the expression of inducible nitric oxide synthase in rat neutrophils. Br. J. Pharmacol. 114:1995;1105-1106.
39. Mariotto S., Cuzzolin L., Adami A., Del Soldato P., Suzuki H., Benoni G. Effect of a new non-steroidal anti-inflammatory drug, nitroflurbiprofen, on the expression of inducible nitric oxide synthase in rat neutrophils. Br. J. Pharmacol. 115:1995;225-226.
40. Massa P.T., Wu C. Increased inducible activation of NF-kappaB and responsive genes in astrocytes deficient in the protein tyrosine phosphatase SHP-1. J. Interferon Cytokine Res. 18:1998;499-507.
41. Matthews J.R., Botting C.H., Panico M., Morris H.R., Hay R.T. Inhibition of NF-kappaB DNA binding by nitric oxide. Nucleic Acids Res. 24:1996;2236-2242.
42. May M.J., Ghosh S. Signal transduction through NF-kappa B. Immunol. Today. 19:1998;80-88.
43. Moncada S., Higgs A., Furchgott R. International Union of Pharmacology Nomenclature in Nitric Oxide Research. Pharmacol. Rev. 49:1997;137-142.
44. Nishiya T., Uehara T., Nomura Y. Herbimycin A suppresses NF-kappa B activation and tyrosine phosphorylation of JAK2 and the subsequent induction of nitric oxide synthase in C6 glioma cells. FEBS Lett. 371:1995;333-336.
45. Nunokawa Y., Ishida N., Tanaka S. Promoter analysis of human inducible nitric oxide synthase gene associated with cardiovascular homeostasis. Biochem. Biophys. Res. Commun. 200:1994;802-807.
46. O'Neill L.A., Kaltschmidt C. NF-kappa B A crucial transcription factor for glial and neuronal cell function . Trends Neurosci. 20:1997;252-258.
47. Pahan K., Sheikh F.G., Khan M., Namboodiri A.M., Singh I. Sphingomyelinase and ceramide stimulate the expression of inducible nitric-oxide synthase in rat primary astrocytes. J. Biol. Chem. 273:1998;2591-2600.
48. Park S.K., Lin H.L., Murphy S. Nitric oxide regulates nitric oxide synthase-2 gene expression by inhibiting NF-kappaB binding to DNA. Biochem. J. 322:1997;609-613.
49. Peng H.B., Libby P., Liao J.K. Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. J. Biol. Chem. 270:1995;14214-14219.
50. Peng H.B., Rajavashisth T.B., Libby P., Liao J.K. Nitric oxide inhibits macrophage-colony stimulating factor gene transcription in vascular endothelial cells. J. Biol. Chem. 270:1995;17050-17055.
51. Peng H.B., Spiecker M., Liao J.K. Inducible nitric oxide An autoregulatory feedback inhibitor of vascular inflammation . J. Immunol. 161:1998;1970-1976.
52. Persichini T., Colasanti M., Lauro G.M., Ascenzi P. Cysteine nitrosylation inactivates the HIV-1 protease. Biochem. Biophys. Res. Commun. 250:1998;575-576.
53. Persichini T., Colasanti M., Fraziano M., Colizzi V., Ascenzi P., Lauro G.M. Nitric oxide inhibits HIV-1 replication in human astrocytoma cells. Biochem. Biophys. Res. Commun. 254:1999;200-202.
54. Persichini T., Colasanti M., Fraziano M., Colizzi V., Medana C., Polticelli F., Venturini G., Ascenzi P. Nitric oxide inhibits the HIV-1 reverse transcriptase activity. Biochem. Biophys. Res. Commun. 258:1999;624-627.
55. Polazzi E., Levi G., Minghetti L. Human immunodeficiency virus type 1 Tat protein stimulates inducible nitric oxide synthase expression and nitric oxide production in microglial cultures. J. Neuropathol. Exp. Neurol. 58:1999;825-831.
56. Rodriguez-Ariza A., Paine A.J. Rapid induction of NF-kappaB binding during liver cell isolation and culture Inhibition by L-NAME indicates a role for nitric oxide synthase . Biochem. Biophys. Res. Commun. 257:1999;145-148.
57. Schroeder R.A., Cai C., Kuo P.C. Endotoxin-mediated nitric oxide synthesis inhibits IL-1β gene transcription in ANA-1 murine macrophages. Am. J. Physiol. 277:1999;C523-C530.
58. Sekkai D., Aillet F., Israel N., Lepoivre M. Inhibition of NF-kappaB and HIV-1 long terminal repeat transcriptional activation by inducible nitric oxide synthase 2 activity. J. Biol. Chem. 273:1998;3895-3900.
59. Sen R., Baltimore D. Inducibility of k immunoglobulin enhancer-binding protein NF-kB by a posttranslational mechanism. Cell. 47:1986;921-928.
60. Shin W.S., Hong Y.H., Peng H.B., De Caterina R., Libby P., Liao J.K. Nitric oxide attenuates vascular smooth muscle cell activation by interferon-gamma. The role of constitutive NF-kappa B activity. J. Biol. Chem. 271:1996;11317-11324.
61. Simpson C.S., Morris B.J. Activation of nuclear factor kappaB by nitric oxide in rat striatal neurones Differential inhibition of the p50 and p65 subunits by dexamethasone . J. Neurochem. 73:1999;353-361.
62. Spiecker M., Peng H.B., Liao J.K. Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of IkappaBalpha. J. Biol. Chem. 272:1997;30969-30974.
63. Spiecker M., Darius H., Kaboth K., Hubner F., Liao J.K. Differential regulation of endothelial cell adhesion molecule expression by nitric oxide donors and antioxidants. J. Leukoc. Biol. 63:1998;732-739.
64. Taylor B.S., Kim Y.M., Wang Q., Shapiro R.A., Billiar T.R., Geller D.A. Nitric oxide down-regulates hepatocyte-inducible nitric oxide synthase gene expression. Arch. Surg. 132:1997;1177-1183.
65. Togashi H., Sasaki M., Frohman E., Taira E., Ratan R.R., Dawson T.M., Dawson V.L. Neuronal (type I) nitric oxide synthase regulates nuclear factor kappaB activity and immunologic (type II) nitric oxide synthase expression. Proc. Natl. Acad. Sci. USA. 94:1997;2676-2680.
66. Tornatore C., Chandra R., Berger J.R., Major E.O. HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology. 44:1994;481-487.
67. Toyoshima T., Kamijo R., Takizawa K., Sumitani K., Hatori M., Nagumo M. Nitric oxide up-regulates the expression of intercellular adhesion molecule-1 on cancer cells. Biochem. Biophys. Res. Commun. 257:1999;395-399.
68. Tsao P.S., Wang B., Buitrago R., Shyy J.Y., Cooke J.P. Nitric oxide regulates monocyte chemotactic protein-1. Circulation. 96:1997;934-940.
69. Umansky V., Hehner S.P., Dumont A., Hofmann T.G., Schirrmacher V., Dröge W., Schmitz M.L. Co-stimulatory effect of nitric oxide on endothelial NF-kappaB implies a physiological self-amplifying mechanism. Eur. J. Immunol. 28:1998;2276-2282.
70. Verma I.M., Stevenson J. IkappaB kinase Beginning, not the end . Proc. Natl. Acad. Sci. USA. 94:1997;11758-11760.
71. von Knethen A., Callsen D., Brune B. NF-kappaB and AP-1 activation by nitric oxide attenuated apoptotic cell death in RAW 264.7 macrophages. Mol. Biol. Cell. 10:1999;361-372.
72. Xie Q.W., Kashiwabara Y., Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269:1994;4705-4708.
73. Zeiher A.M., Fisslthaler B., Schray Utz B., Busse R. Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circ. Res. 76:1995;980-986.
74. Zhang J., Velsor L.W., Patel J.M., Postlethwait E.M., Block E.R. Nitric oxide-induced reduction of lung cell and whole lung thioredoxin expression is regulated by NF-κB. Am. J. Physiol. 277:1999;L787-L793.